- Verdi Oncology is an oncology practice management company founded in 2018 in partnership with Pharos Capital – a physician-founded private equity firm. Pharos Capital is focused on growing healthcare companies that lower the total cost of care, improve patient outcomes and expand access to care.
- Headquartered in Brentwood, Tennessee with practice locations across the U.S., we empower oncology practices, physicians, and hospitals to create value through high quality, low cost, patient centric oncology care.
- Verdi was founded on the belief that cancer treatment should be patient centric and value based. To this end, we have invested heavily in five core components of our Verdi Excellence program: patient experience, patient growth, clinical pathways, practice efficiency and value-based care.
- We will continue to be pioneers in the field of oncological care and, with the help of members of our network, improve cancer treatment for our patients and their families.
William (Bill) M. Herman
Chief Executive Officer (CEO)
Bill is a proven business executive with a history of starting and building successful business units for large global companies. He specializes in helping companies achieve new levels of growth.
He is currently utilizing his over 35 years of experience in management, finance, product/service development, and marketing to assist business leaders in achieving initial or next-level growth.
Bill was most recently with McKesson Specialty Health, a business unit of McKesson (MCK). As the Senior Vice President, he was responsible for growing the depth, reach, and operational performance of US Oncology’s practices in Florida. Bill joined US Oncology (purchased by MCK in 2010) in 2001, where he held leadership positions that helped build over 36 standalone cancer centers, grew the Radiation and Imaging service line, and developed a comprehensive quality program grounded in Six Sigma in an effort to compete in a value-based reimbursement environment. To support the cultural change needed to be successful in the rapidly changing healthcare industry, he led the creation of, and taught at, US Oncology’s Leadership Institute.
Prior to joining US Oncology, Bill spent 20 years with General Electric. During his tenure with GE, Bill held a wide-range of financial, product development, and operational positions in GE
Healthcare, GE Motors, and various corporate departments. He has held executive roles in financial management, global product and services development business units, and started a consulting business focused on bringing Six Sigma to healthcare.
Bill was the focus of a Harvard Business School case study on the transformation of a GE business unit, speaker at several US and European Conferences, and featured in a Fortune Magazine article. Additionally, Bill has co-authored articles on building cancer centers, improving medical practice quality, service and productivity; and change management.
Bill is a Board Member of SpringSpirit, a Houston organization focused on developing at-risk
Bill graduated from Auburn University with a B.S. in Business Administration and is a non-practicing CPA. Bill and his wife of 42 years have five children and seven grandchildren.
Chief Financial Officer (CFO)
Audrey has over 20 years of experience providing operational and financial support and leadership at various outpatient healthcare companies as well as a background in investment banking.
She has held senior leadership positions and provided consulting services at various private equity-backed companies as well.
Audrey and her husband Kevin have two 2 children. She enjoys tennis, camping, and spends most of her free time running around to sporting events for her kids.
Senior Vice President of Clinical Operations
Carolyn Craig is the Senior Vice President of Clinical Operations at Verdi. In this role, she oversees clinical services, as well as transformational clinical and quality initiatives.
Carolyn began her career in healthcare as a registered nurse in the operating room. She joined HCA Information Technology Services during the early product development and implementation of integrated clinical systems. She has served in a variety of roles since then, including senior level healthcare project management, process improvement facilitation, and clinical workflow optimization. Her roles were in both large and small healthcare organizations, with the last 20 years focused on community oncology.
Carolyn joined Verdi Oncology in 2019, focusing on optimization and growth of practices. In 2020, she led Verdi’s pandemic response and team, resulting in reduced disruption of care for oncology patients. Recently, she is leading efforts to bring expanded integrated oncology opportunities into Verdi practices, with a focus on improving the oncology patient’s experience.
She holds a Bachelor of Science in Nursing degree from Belmont University and an Associates of Science degree from Aquinas College. She enjoys organic gardening, traveling, and spending time with friends and family.
Senior Vice President of Strategic Growth
Brian has deep experience and leadership in public and private healthcare and technology organizations, with demonstrated success in building high-growth businesses with scalable processes. Brian’s previous experience includes senior and executive leadership roles at US Oncology and Raintree Oncology Services
His achievements include scaling a unique, member-owned national network of top oncology practices to improve patient outcomes, lower costs, and increase practice revenues. He also developed one of the first Accountable Care Organizations (ACO) with Hospital/Primary Care
Brian has broad experience with Specialty Distribution, Diagnostics and Genomics. He is a certified Six Sigma Black Belt.
Dr. Amy Cripps
Medical Director of Clinical Ops
Dr. Amy Cripps is a board-certified medical oncologist. She joined Verdi Oncology Texas in 2019 as a practicing physician before moving to Denver, Colorado. She is the Medical Director of Clinical Operations.
She was born in Austin, Texas, and grew up in Phoenix, Arizona with her parents, one brother, and four sisters. She received a Bachelor of Science from University of Mary Hardin-Baylor in Belton, Texas in 1999. She received her Medical Doctorate degree from University of Texas Houston Health Science Center in 2003. Postmedical school training including internal medicine residency, chief resident, and medical oncology fellowship was done in the Oakland-San Francisco Bay area and completed in 2010. By that time, she had married her medical school sweetheart and moved to Dallas, Texas with her husband, who is a trauma surgeon, and their first child.
She joined NexGen Oncology in 2013, and in 2019, joined Verdi Oncology Texas. She practiced in Dallas until her family recently moved to Denver, Colorado. She is now working with Verdi as Medical Director of Clinical Operations. She has two children, Olivia age 10, and Joshua, age 6. She enjoys reading, cooking, hiking, and skiing.
Dr. Ajita Narayan
Senior Associate Research Director, Horizon Oncology Research
Dr. Narayan has been at Horizon Oncology, a Verdi partner, since 2011. In addition to a full-time clinical practice, she has a particular interest in clinical research and heads the Horizon arm of Research.
Dr. Ajita Narayan was trained in India at Goa Medical College. She pursued a Ph.D. in biochemistry at Tulane University followed by a research post doctoral fellowship at University of Michigan that focused on head and neck cancer. Her residency was subsequently finished in Internal Medicine at St. Luke’s Hospital in St. Louis, Missouri, where she stayed on for a year as chief resident. Her hematology oncology fellowship was completed at Case Western Reserve University in Cleveland, OH in 2009 before moving to Lafayette, Indiana.
At Horizon Oncology, one of her primary focuses is on multiple Phase 1 and Phase 2 studies that help patients from around the US after standard cancer therapies have been exhausted.
She enjoys spending time with her family and their numerous animals. She is very fond of jazz, Indian classical music and dance, gardening, and baking.
Lisa Petro, CPC, MCS-P
Director of Revenue Cycle Operations
Lisa has over 28 years of experience in revenue cycle management and regulatory compliance with medical practices that range from independent practitioners to inpatient hospital services.
Lisa Petro has lived in middle Tennessee her entire life. She grew up in rural Williamson County. She was the youngest of a very large family.
She has developed an expertise in multi-specialties related billing and compliance. She is certified in physician compliance and is a certified coder. Lisa consults on a national level on eligibility of services, assignment of reimbursement level by complexity and protocols, and
documentation methodology to meet regulatory requirements and audit compliance.
She also has strong experience in startup and growing organizations and will be a critical resource for Verdi in developing reimbursement goals and establishing revenue processes in a way to simplify the company’s success and comply with regulatory and industry standards.
When not working to collect revenue for Verdi, Lisa can be found boating with her family on the beautiful Tennessee lakes.
Elizabeth A. Morris
Assistant Director of Clinical Research for Verdi Oncology Research
Elizabeth is the Assistant Director of Clinical Research for Horizon Oncology and is responsible for overseeing Phase I-IV clinical trial sites to ensure the smooth operation and effectiveness of clinical trials.
This includes planning through opening and completion of the trials by assuring that the processes, integrity, and quality of the research is assessed and maintained, and that the trials are conducted in accordance with Good Clinical Practice Guidelines, federal and sponsor regulations and guidelines, and Verdi Policy and Procedure.
She has been an RN since 1998 and has been with Horizon Oncology since 2002, where she began as an Infusion RN, working in that position for seven years before transitioning to the Research Department. After transitioning to Research, Elizabeth became the Research Coordinator where she was in charge of multiple Phase 1 trials, before becoming the Clinical Research Team Lead, Research Manager, and most recently, the Assistant Director of Clinical Research. During her time at Horizon, she obtained her OCN (Oncology Certified Nurse) in 2004 and her CCRC (Certified Clinical Research Coordinator) in 2013.
Mike leads Verdi Oncology’s accounting and finance team, where he oversees and assesses internal controls, financial reporting, asset management, and forecasting.
Mike Hinote joined the Verdi Team in February 2021 as the Corporate Controller. Since joining the team, Mike leads the accounting and finance team where he oversees and assesses internal controls, financial reporting, asset management, and forecasting. Mike is a CPA with over 15 years of experience in public accounting and industry and prior to joining Verdi provided support and leadership to private equity-backed companies like Verdi.
Dani Allen is the leader of the Human Resources Department. Before discovering her love of Human Resources in small and medium sized healthcare organizations, she worked in various industries, organization sizes, and areas of HR.
With an expertise in Employment Law, Compliance and the natural gift of gab, Dani balances her analytical thinking and her connections with others to create a culture that employees are proud of.
When she isn’t reading about changes to legislation, Dani enjoys dancing ballet, practicing her Spanish language skills, and spending time with friends.